Bayer’s Lampit Has Unique Status: US FDA’s Most ‘Critical’ Approval In 2020
• By Michael McCaughan
FDA inspectors took a trip to Bayer’s facility in Leverkusen, Germany for a pre-approval inspection during the pandemic. • Source: photo illustration/Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
